company background image
IMCC logo

IM Cannabis NasdaqCM:IMCC Stock Report

Last Price

US$1.97

Market Cap

US$4.6m

7D

-3.9%

1Y

-27.8%

Updated

04 Nov, 2024

Data

Company Financials +

IM Cannabis Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for IM Cannabis
Historical stock prices
Current Share PriceCA$1.97
52 Week HighCA$8.10
52 Week LowCA$1.13
Beta1.68
11 Month Change-13.22%
3 Month Change-34.37%
1 Year Change-27.84%
33 Year Change-98.78%
5 Year Changen/a
Change since IPO-98.39%

Recent News & Updates

Recent updates

IM Cannabis Shareholder Rafael Gabay raises stake

Sep 08

IM Cannabis GAAP EPS of -C$0.30, revenue of C$23.8M

Aug 15

IM Cannabis receives non-compliance notification from Nasdaq for minimum bid price requirement

Jul 19

cbdMD And IM Cannabis Partner To Sell CBD Products In Israeli Markets

Aug 14

IM Cannabis proposes public offering of securities

May 05

IM Cannabis acquires Israel's largest retail and online pharmacy business from Panaxia

Apr 30

Shareholder Returns

IMCCUS PharmaceuticalsUS Market
7D-3.9%-3.7%-1.6%
1Y-27.8%17.2%30.8%

Return vs Industry: IMCC underperformed the US Pharmaceuticals industry which returned 17.2% over the past year.

Return vs Market: IMCC underperformed the US Market which returned 30.8% over the past year.

Price Volatility

Is IMCC's price volatile compared to industry and market?
IMCC volatility
IMCC Average Weekly Movement8.9%
Pharmaceuticals Industry Average Movement9.3%
Market Average Movement6.0%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

Stable Share Price: IMCC has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: IMCC's weekly volatility has decreased from 21% to 9% over the past year.

About the Company

FoundedEmployeesCEOWebsite
200895Oren Shusterimcannabis.com

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients.

IM Cannabis Corp. Fundamentals Summary

How do IM Cannabis's earnings and revenue compare to its market cap?
IMCC fundamental statistics
Market capUS$4.64m
Earnings (TTM)-US$10.10m
Revenue (TTM)US$35.74m

0.1x

P/S Ratio

-0.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IMCC income statement (TTM)
RevenueCA$49.88m
Cost of RevenueCA$43.77m
Gross ProfitCA$6.11m
Other ExpensesCA$20.20m
Earnings-CA$14.09m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-6.31
Gross Margin12.25%
Net Profit Margin-28.25%
Debt/Equity Ratio276.4%

How did IMCC perform over the long term?

See historical performance and comparison